Join Growin Stock Community!
Back to LLY.US Analysis
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

revenue-chart

LLY Revenue

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

As of Q4'25, Eli Lilly (LLY) reported revenue of USD 19.29B, marking the highest quarterly revenue in the period covered. Year-over-year revenue growth for this quarter reached 42.56%, reflecting a robust acceleration compared to previous quarters. From Q1'23 to Q4'25, LLY's revenue demonstrated a strong upward trend, rising from USD 6.96B to USD 19.29B. After a slight decline in Q1'23, the company experienced consistent growth, with notable surges in Q2'24 and Q3'25. Year-over-year growth rates remained positive throughout most of the period, peaking at 53.87% in Q3'25, indicating sustained momentum and significant expansion in recent quarters.